P0398 Eligibility for adjuvant pembrolizumab and real-world survival outcomes in Portuguese clear cell renal cell carcinoma: A multicenter national study

European Urology 2026

View at publisher
Authors: B. Oliveira, S. Bastos, F. Quintas, V. Chambel, T. Sousa, M. Vasconcelos, P.L. Fernades, VT Oliveira, dos Reis J.P. Palma, A. Fraga, M. Ramos
DOI: 10.1016/s0302-2838(26)01292-3
Cited by: 0

Fields of Study & Subjects

Renal cell carcinoma treatment Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
European Urology
Volume
89
Pages
S1–S2
Publication date
13 February 2026
Language
EN